MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

64.72 +0.57 (+0.89%)
Official Closing Price Updated: 7:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,212,879
Open 64.24
Bid (Size) 64.06 (1,100)
Ask (Size) 64.70 (1,000)
Prev. Close 64.15
Today's Range 63.79 - 64.73
52wk Range 42.52 - 68.10
Shares Outstanding 2,222,113,553
Dividend Yield 3.89%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bristol-Myers Squibb’s Q2 Earnings Call: Our Top 5 Analyst Questions
Bristol Myers Squibb’s second quarter results were marked by strong contributions from its growth portfolio, leading to a positive market reaction. Managemen... 
Via StockStory
Topics Earnings
News headline image
Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript ↗
Growth portfolio now drives 60% of revenue as Eliquis surges 21%. 
Via The Motley Fool
Topics Earnings

Performance

YTD
+21.1%
+21.1%
1 Month
+12.5%
+12.5%
3 Month
+15.2%
+15.2%
6 Month
+4.4%
+4.4%
1 Year
+42.7%
+42.7%

More News

Read More
Which S&P500 stocks are moving before the opening bell on Monday? ↗
Via Chartmill
Bristol-Myers Squibb (NYSE:BMY) Surges on Q2 Earnings Beat, Raises Full-Year Guidance ↗
Via Chartmill
Topics Earnings
Bristol Myers Squibb Co (NYSE:BMY): A High Yield Dividend Stock Backed by Strong Profitability ↗
Via Chartmill
News headline image
Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook
Via StockStory
News headline image
Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Why Bristol Myers Squibb Stock Topped the Market on Thursday ↗
Via The Motley Fool
News headline image
Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
Via StockStory
News headline image
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow
Via StockStory
News headline image
This Healthcare Leader Just Made a Bet on Artificial Intelligence (AI): Time to Buy the Stock? ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
My 3 Favorite Artificial Intelligence (AI) Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Electric Vehicles
News headline image
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now ↗
Via MarketBeat
Topics Economy
News headline image
Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Via StockStory
News headline image
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring ↗
Via The Motley Fool
News headline image
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
From Bristol Myers Squibb
Via Business Wire
News headline image
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb ↗
Via The Motley Fool
Topics Government Intellectual Property
News headline image
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
From Bristol Myers Squibb
Via Business Wire
News headline image
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 64.72
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 08/07/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 143.82B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 144B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story